Human Metabolome Technologies (TSE:6090) Total Inventories: 円40.3 Mil (As of Dec. 2025)

What is Human Metabolome Technologies Total Inventories?

Human Metabolome Technologies TSE:6090 +0.84% 59 Total Inventories is 円40.3 Mil as of Dec. 2025. GuruFocus rates TSE:6090 with a GF Score™ of 59/100 and a GF Value™ of 円529.55 (Modestly Overvalued). The stock has 4 warning signs investors should review.

Human Metabolome Technologies's total inventories for the quarter that ended in Dec. 2025 was 円40.3 Mil. Human Metabolome Technologies's average total inventories from the quarter that ended in Sep. 2025 to the quarter that ended in Dec. 2025 was 円51.5 Mil.

In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. Human Metabolome Technologies's Net-Net Working Capital per share for the quarter that ended in Dec. 2025 was 円207.84.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year. Human Metabolome Technologies's Inventory Turnover for the quarter that ended in Dec. 2025 was 0.00.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Human Metabolome Technologies (TSE:6090) Total Inventories Explanation

Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.

1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.

Human Metabolome Technologies's Net-Net Working Capital Per Share for the quarter that ended in Dec. 2025 is

	Net-Net Working Capital Per Share (Q: Dec. 2025 )
=	(Cash And Cash Equivalents	+	0.75 * Accounts Receivable	+	0.5 * Total Inventories	-	Total Liabilities
-	Preferred Stock	-	Minority Interest)	/	Shares Outstanding (EOP)
=	(1208.566	+	0.75 * 360.368	+	0.5 * 40.296	-	329.269
-	0	-	0)	/	5.628
=	207.84

2. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Human Metabolome Technologies's Days Inventory for the three months ended in Dec. 2025 is calculated as:

Days Inventory	=	Average Total Inventories (Q: Dec. 2025 )	/	Cost of Goods Sold (Q: Dec. 2025 )	*	Days in Period
	=	51.4755	/	0	*	365 / 4
	=

3. Inventory Turnover measures how fast the company turns over its inventory within a year.

Human Metabolome Technologies's Inventory Turnover for the quarter that ended in Dec. 2025 is calculated as

Inventory Turnover	=	Cost of Goods Sold (Q: Dec. 2025 )	/	Average Total Inventories (Q: Dec. 2025 )
	=	0	/	51.4755
	=	0.00

4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Human Metabolome Technologies's Inventory to Revenue for the quarter that ended in Dec. 2025 is calculated as

Inventory-to-Revenue	=	Average Total Inventories (Q: Dec. 2025 )	/	Revenue (Q: Dec. 2025 )
	=	51.4755	/	0
	=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Be Aware

Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.

When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.

Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.

Human Metabolome Technologies Total Inventories Related Terms

Human Metabolome Technologies Total Inventories Historical Data

* Premium members only.

The historical data trend for Human Metabolome Technologies's Total Inventories can be seen below:

Human Metabolome Technologies Total Inventories Chart

Human Metabolome Technologies Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Jun20

Jun21

Jun22

Jun23

Jun24

Total Inventories

Get a 7-Day Free Trial

70.64

34.80

43.40

26.22

36.99

Human Metabolome Technologies Quarterly Data
	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
Total Inventories	Get a 7-Day Free Trial															55.62	51.15	62.66	40.30	50.76

59GF Score

Human Metabolome Technologies Inc TSE:6090

Total Inventories is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Human Metabolome Technologies Total Inventories Calculation

Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.

Frequently Asked Questions Learn more about Total Inventories →

What does a Total Inventories of 円40.3 Mil mean?

Human Metabolome Technologies (TSE:6090) has a Total Inventories of 円40.3 Mil as of Dec. 2025. The total amount of inventory as recorded on a company's balance sheet. View historical data for Human Metabolome Technologies and its competitors.

Is Human Metabolome Technologies' Total Inventories too high?

Human Metabolome Technologies' current Total Inventories is 円40.3 Mil. Overall, Human Metabolome Technologies has a GF Score™ of 59/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.

How does Human Metabolome Technologies' Total Inventories compare to TMO and DHR?

Human Metabolome Technologies' Total Inventories of 円40.3 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good Total Inventories for a Medical Diagnostics & Research company?

A good Total Inventories depends on the Medical Diagnostics & Research industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high Total Inventories mean?

A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for Human Metabolome Technologies and its competitors. Human Metabolome Technologies's current Total Inventories is 円40.3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Human Metabolome Technologies stock overvalued right now?

Based on GuruFocus' analysis, Human Metabolome Technologies (TSE:6090) is currently considered Modestly Overvalued. The stock's GF Value™ is 円529.55, compared to a current price of 円598.00 — trading 12.9% above its estimated fair value. The current Total Inventories is 円40.3 Mil. Human Metabolome Technologies' overall GF Score™ is 59/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is Total Inventories calculated?

Total Inventories is calculated from a company's financial statements. For Human Metabolome Technologies (TSE:6090), the current Total Inventories is 円40.3 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Human Metabolome Technologies (TSE:6090) Overvalued in 2026?

Based on GuruFocus' analysis, Human Metabolome Technologies stock appears to be overvalued. The current stock price of 円598.00 is trading 12.9% above its estimated GF Value™ of 円529.55. GuruFocus considers Human Metabolome Technologies to be Modestly Overvalued.

Key valuation signals for TSE:6090:

Total Inventories: 円40.3 Mil
GF Value™: 円529.55 vs. price of 円598.00 (12.9% above fair value)
GF Score™: 59/100 with 4 warning signs

No single metric tells the full story. See the TSE:6090 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Human Metabolome Technologies Business Description

Industry Healthcare Medical Diagnostics & Research

Comparable Companies TSE:3386 TMO DHR SHSE:603259 XSWX:LONN IDXX A NTRA WAT IQV ILMN MTD DGX LH GH MEDP XPAR:ERF ICLR RVTY CRL

Address Yamagata Prefecture Kakuganji Water 246-2, Tsuruoka, JPN, 997-0052

Website http://www.humanmetabolome.com

Human Metabolome Technologies Inc is involved in the search and diagnosis of biomarkers and commercialization in the field of drug development.

59GF Score

Get the complete analysis for TSE:6090

Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円598.00

Price

円529.55

GF Value

View TSE:6090 Analysis

See Total Inventories data for all stocks →